Approval of Baclofen for Alcohol Use Disorders in France: A Perspective From the United States
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

Approval of Baclofen for Alcohol Use Disorders in France: A Perspective From the United States

Garbutt, James C;
alcohol and alcoholism 2020 Vol. 55 pp. 48-48
146
c2020alcoholapproval

Abstract

The recent approval of baclofen for the treatment of alcohol use disorders (AUDs) in France is notable as baclofen is now the sixth chemical entity (disulfiram,

Keywords

Access

URL:
https://doi.org/10.1093/alcalc/agz084

Citation

ID: 269204
Ref Key: c2020alcoholapproval
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
269204
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store